摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5R,6R,7R,8S)-6,7-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydrotriazolo[4,3-a]pyridin-8-ol | 182074-17-5

中文名称
——
中文别名
——
英文名称
(5R,6R,7R,8S)-6,7-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydrotriazolo[4,3-a]pyridin-8-ol
英文别名
(5R,6R,7R,8R)-6,7-bis(phenylmethoxy)-5-(phenylmethoxymethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-ol
(5R,6R,7R,8S)-6,7-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydrotriazolo[4,3-a]pyridin-8-ol化学式
CAS
182074-17-5
化学式
C28H29N3O4
mdl
——
分子量
471.556
InChiKey
MJGNIQHWTZOHSP-HVWQDESWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    35
  • 可旋转键数:
    10
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    78.6
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    (5R,6R,7R,8S)-6,7-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydrotriazolo[4,3-a]pyridin-8-ol 在 palladium on activated charcoal 吡啶 、 sodium azide 、 氢气 作用下, 以 甲醇溶剂黄146N,N-二甲基甲酰胺 为溶剂, 70.0 ℃ 、600.0 kPa 条件下, 反应 26.5h, 生成 (5R,6R,7S,8S)-8-amino-5,6,7,8-tetrahydro-5-(hydroxymethyl)[1,2,4]triazolo[4,3-a]pyridine-6,7-diol
    参考文献:
    名称:
    摘要:
    The inhibition of the beta-glucosidases from sweet almonds and Caldocellum saccharolyticum at varying pH values by the glucosamine-related inhibitors 1-7 has been compared to the inhibition by the known glucose analogues 8-14. The amino derivatives 3, 4, 6, and 7 were prepared in one step from the known 15-18 (Scheme I), and the amino-1,2,3-triazole 5 by a variant of the synthesis leading to the glucose analogue 12 (Scheme 2). The key step Tor the preparation of the aminoimidazole 1 and of the amino-1,2,4-triazole 2 is the regioselective cleavage of the benzyloxy group at C(2) of the gluconolactam 35 and the mannonolactam 57 respectively, by BCl3 and B4NBr (Schemes 3 and 4, resp.). The pH optimum for the inhibition by the amines is lower than their pK(HA) values, evidencing that they are bound as ammonium salts and that H-bonding between C(2)-NH3+ and the cat. base B- contributes more strongly to binding than any possible H-bond to the NH2-C(2) group. The influence of the ammonium group on the inhibitory strength correlates with the basicity of the 'glycosidic heteroatom'. The strongest increase of the inhibitory strength is observed for the amines lacking a 'glycosidic heteroatom' (Delta Delta G(OH-->NH3+)=-1.5 to -2.9 kcal/mol). The increase is less; derivatives 3-4, which possess a weakly basic 'glycosidic heteroatom' pronounced for the amino derivatives 3-4, which possess a weakly basic 'glycosidic heteroatom' (Delta Delta G(OH --> NH3+) = - 0.6 to - 1.1 kcal/mol); the amino compounds 1 and 2, which possess a strongly basic 'glycosidic heteroatom', are weaker inhibitors than the corresponding hydroxy compounds, as expressed by Delta Delta G(OH-->NH3+) between +4.3 and +4.7 kcal/mol for the amino-imidazole 1, and between +2.3 and 2.8 kcal/mol for the amino-1,2,4-triazole 2, denoting the dominant detrimental influence of a C(2) -NH3+ group on the H-bond acceptor properties of a sufficiently basic 'glycosidic heteroatom'.
    DOI:
    10.1002/(sici)1522-2675(20000315)83:3<513::aid-hlca513>3.0.co;2-1
  • 作为产物:
    描述:
    2-O-acetyl-5-amino-3,4,6-tri-O-benzyl-5-deoxy-D-mannonothiolactam 在 mercury(II) diacetate 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 3.5h, 生成 (5R,6R,7R,8S)-6,7-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydrotriazolo[4,3-a]pyridin-8-ol
    参考文献:
    名称:
    摘要:
    The inhibition of the beta-glucosidases from sweet almonds and Caldocellum saccharolyticum at varying pH values by the glucosamine-related inhibitors 1-7 has been compared to the inhibition by the known glucose analogues 8-14. The amino derivatives 3, 4, 6, and 7 were prepared in one step from the known 15-18 (Scheme I), and the amino-1,2,3-triazole 5 by a variant of the synthesis leading to the glucose analogue 12 (Scheme 2). The key step Tor the preparation of the aminoimidazole 1 and of the amino-1,2,4-triazole 2 is the regioselective cleavage of the benzyloxy group at C(2) of the gluconolactam 35 and the mannonolactam 57 respectively, by BCl3 and B4NBr (Schemes 3 and 4, resp.). The pH optimum for the inhibition by the amines is lower than their pK(HA) values, evidencing that they are bound as ammonium salts and that H-bonding between C(2)-NH3+ and the cat. base B- contributes more strongly to binding than any possible H-bond to the NH2-C(2) group. The influence of the ammonium group on the inhibitory strength correlates with the basicity of the 'glycosidic heteroatom'. The strongest increase of the inhibitory strength is observed for the amines lacking a 'glycosidic heteroatom' (Delta Delta G(OH-->NH3+)=-1.5 to -2.9 kcal/mol). The increase is less; derivatives 3-4, which possess a weakly basic 'glycosidic heteroatom' pronounced for the amino derivatives 3-4, which possess a weakly basic 'glycosidic heteroatom' (Delta Delta G(OH --> NH3+) = - 0.6 to - 1.1 kcal/mol); the amino compounds 1 and 2, which possess a strongly basic 'glycosidic heteroatom', are weaker inhibitors than the corresponding hydroxy compounds, as expressed by Delta Delta G(OH-->NH3+) between +4.3 and +4.7 kcal/mol for the amino-imidazole 1, and between +2.3 and 2.8 kcal/mol for the amino-1,2,4-triazole 2, denoting the dominant detrimental influence of a C(2) -NH3+ group on the H-bond acceptor properties of a sufficiently basic 'glycosidic heteroatom'.
    DOI:
    10.1002/(sici)1522-2675(20000315)83:3<513::aid-hlca513>3.0.co;2-1
点击查看最新优质反应信息

文献信息

  • Synthesis and Glycosidase Inhibitory Activities of Nagstatin Triazole Analogs.
    作者:KUNIAKI TATSUTA、YUICHI IKEDA、SHOZO MIURA
    DOI:10.7164/antibiotics.49.836
    日期:——
  • ——
    作者:Narendra Panday、Muthuppalaniappan Meyyappan、Andrea Vasella
    DOI:10.1002/(sici)1522-2675(20000315)83:3<513::aid-hlca513>3.0.co;2-1
    日期:2000.3.15
    The inhibition of the beta-glucosidases from sweet almonds and Caldocellum saccharolyticum at varying pH values by the glucosamine-related inhibitors 1-7 has been compared to the inhibition by the known glucose analogues 8-14. The amino derivatives 3, 4, 6, and 7 were prepared in one step from the known 15-18 (Scheme I), and the amino-1,2,3-triazole 5 by a variant of the synthesis leading to the glucose analogue 12 (Scheme 2). The key step Tor the preparation of the aminoimidazole 1 and of the amino-1,2,4-triazole 2 is the regioselective cleavage of the benzyloxy group at C(2) of the gluconolactam 35 and the mannonolactam 57 respectively, by BCl3 and B4NBr (Schemes 3 and 4, resp.). The pH optimum for the inhibition by the amines is lower than their pK(HA) values, evidencing that they are bound as ammonium salts and that H-bonding between C(2)-NH3+ and the cat. base B- contributes more strongly to binding than any possible H-bond to the NH2-C(2) group. The influence of the ammonium group on the inhibitory strength correlates with the basicity of the 'glycosidic heteroatom'. The strongest increase of the inhibitory strength is observed for the amines lacking a 'glycosidic heteroatom' (Delta Delta G(OH-->NH3+)=-1.5 to -2.9 kcal/mol). The increase is less; derivatives 3-4, which possess a weakly basic 'glycosidic heteroatom' pronounced for the amino derivatives 3-4, which possess a weakly basic 'glycosidic heteroatom' (Delta Delta G(OH --> NH3+) = - 0.6 to - 1.1 kcal/mol); the amino compounds 1 and 2, which possess a strongly basic 'glycosidic heteroatom', are weaker inhibitors than the corresponding hydroxy compounds, as expressed by Delta Delta G(OH-->NH3+) between +4.3 and +4.7 kcal/mol for the amino-imidazole 1, and between +2.3 and 2.8 kcal/mol for the amino-1,2,4-triazole 2, denoting the dominant detrimental influence of a C(2) -NH3+ group on the H-bond acceptor properties of a sufficiently basic 'glycosidic heteroatom'.
查看更多

同类化合物

苯甲醇,2-甲基-a-[1-(甲基氨基)环戊基]- 溴-6-甲基[1,2,4]噻唑并[1,5-a]吡啶 乙基[1,2,4]三唑并[1,5-a]吡啶-2-羧酸酯 三(二甲基氨基)(3H-1,2,3-三唑[4,5-b]吡啶-3-基氧代)膦六氟磷酸盐 [1,2,4]噻唑并[4,3-a]吡啶-3-羧酸 [1,2,4]噻唑并[1,5-a]吡啶-8-胺 [1,2,4]噻唑并[1,5-a]吡啶-6-羧酸甲酯 [1,2,4]噻唑并[1,5-a]吡啶-6-羧酸 [1,2,4]噻唑并[1,5-a]吡啶-6-甲腈 [1,2,4]噻唑并[1,5-a]吡啶-6-甲胺 [1,2,4]噻唑并[1,5-a]吡啶-5-羧醛 [1,2,4]噻唑并[1,5-a]吡啶-5-羧酸甲酯 [1,2,4]噻唑并[1,5-a]吡啶-2-羧醛 [1,2,4]三氮唑[1,5-A]吡啶-6-甲醛 [1,2,4]三唑并[4,5-a]吡啶-3-磺酰胺 [1,2,4]三唑并[4,3-a]吡啶-5-羧酸 [1,2,4]三唑并[4,3-a]吡啶-5-硫醇 [1,2,4]三唑并[4,3-A]吡啶-8-胺 [1,2,4]三唑并[4,3-A]吡啶-7-羧酸 [1,2,4]三唑并[1,5-a]吡啶-7-羧酸 [1,2,4]三唑并[1,5-a]吡啶-6-胺 [1,2,4]三唑并[1,5-a]吡啶-5-羧酸 [1,2,4]三唑并[1,5-a]吡啶 [1,2,4]三唑并[1,5-A]吡啶-7-羧酸甲酯 [1,2,4]三唑并[1,5-A]吡啶-7-硼酸 [1,2,4]三唑[4,3-A]嘧啶-6-羧酸 [1,2,4]三唑[4,3-A]吡啶-3-硫醇 [1,2,4]三唑[1,5-a]吡啶-2-甲酸 [1,2,3]三唑并[1,5-a]吡啶-7-甲醛 [1,2,3]三唑并[1,5-a]吡啶-7-甲酰胺 [1,2,3]三唑并[1,5-a]吡啶-3-甲酰胺 [1,2,3]三唑并[1,5-a]吡啶-3-甲酰氯 N-羟基-7-氮杂苯并三氮唑 N-[5-[(1-甲基乙基)氨基]-7-(三氟甲基)[1,2,4]三唑并[1,5-a]吡啶-2-基]-3-吡啶甲酰胺 N,N-二乙基-7-硝基-1H-1,2,3-三唑并[4,5-c]吡啶-1-乙胺 GLPG-0634 中间体 ALK4/ALK5抑制剂 9-环戊基-7-乙基-3-(2-噻吩基)-6,9-二氢-5H-吡唑并[3,4-c][1,2,4]三唑并[4,3-A]吡啶 8-硝基[1,2,4]三唑并[4,3-a]吡啶 8-硝基[1,2,4]三唑并[1,5-a]吡啶 8-甲氧基-[1,2,4]噻唑并[1,5-a]吡啶-2-胺 8-甲氧基-5-碘-[1,2,4]噻唑并[1,5-a]吡啶-2-胺 8-甲基-[1,2,4]三唑并[1,5-A]吡啶 8-甲基-1,2,4噻唑并1,5-a吡啶-2-胺 8-溴2-甲基-[1,2,4]噻唑并[1,5-a]吡啶 8-溴-[1,2,4]噻唑并[1,5-a]吡啶-2-胺 8-溴-[1,2,4]三氮唑并[4,3-A]吡啶 8-溴-[1,2,4]三唑并[1,5-A]吡啶 8-溴-[1,2,4]三唑[4,3-a]吡啶-6-羧酸 8-溴-6-氯-2-甲基-[1,2,4]噻唑并[1,5-a]吡啶